Eric Xu

Founder & Chairman at Cascade Pharmaceutics

Presenter

Cascade Pharmaceuticals is a clinical-stage biotech company advancing innovative treatments for obesity, MASH, diabetes, CKD, and CVD. With $70M raised since 2017, Cascade’s pipeline includes Linafexor, a first-in-class FXR activator enhancing weight loss and reducing GLP-1 doses, and Thybetaxor, a potent thyroid hormone receptor beta agonist with 10x GLP-1 synergy. Focused on reducing muscle loss and improving metabolic outcomes, Cascade is transforming care for metabolic diseases with groundbreaking therapies.